News

Qilu's Provincial Key Laboratory for 'Small Molecule Targeted Drugs' Approved by the Experts's Argu

ABOUT US

News

Qilu's Provincial Key Laboratory for 'Small Molecule Targeted Drugs' Approved by the Experts's Argu

Release time：

2011-06-08

The declaration for Qilu's Provincial Key Laboratory of 'Small Molecule Targeted Drugs' was officially recieved by Provincial Science and Technology Department in March 2011. Recently PSTD organized the relevant experts to perform the argument of the feasibility of this Laboratory. PSTD and the experts were impressed by the initial development of this laboratory. This argument not only provides sugguestions for the further development of this laboratory, but also offers a foundation for final approval of this laboratory.

Qilu Ranks 17th in Top 100 in China’s Medical and Pharmaceutical Industry

Qilu Hainan awarded from governmental support

Related News

Qilu Launches First Generic Version of Invega Sustenna® (Paliperidone Palmitate Suspension for Injection) in China

2023-10-12

Qilu Pharmaceutical launched the first innovative drug in China

2023-09-01

Qilu Pharmaceutical Group Awarded as Socially Responsible Enterprises (Entrepreneurs) in 2022

2023-04-04

Qilu Pharmaceutical ranks No.5 in the list of "Top 100 Enterprises in Chinese Pharmaceutical Industry”

2022-12-19

Qilu Pharmaceutical ranked 5th among China's top 100 list